Indian Journal of Dermatology
: 2021  |  Volume : 66  |  Issue : 2  |  Page : 224-

Koebnerization of lichen sclerosus et atrophicus at insulin injection sites – A rare case with dermoscopic features

Tejas Vishwanath1, Sunil Ghate1, Geeta Shinde1, Vikram Lahoria2, Binny Binny1, Ankita Sonwane1,  
1 Department of Dermatology, Rajawadi Hospital, Mumbai, Maharashtra, India
2 Consultant Dermatologist, Max Super Speciality Hospital, Mohali, Punjab, India

Correspondence Address:
Tejas Vishwanath
Department of Dermatology, Rajawadi Hospital, OPD 18, OPD Building, Ghatkopar (East), Mumbai - 400 077, Maharashtra


Lichen sclerosus et atrophicus (LSEA), also known as lichen sclerosus (LS), is a disabling, cosmetically disfiguring condition predominantly affecting the anogenital region of pre- and postmenopausal females. Extragenital LS is relatively less common and occurs predominantly on the trunk and neck. Koebnerization or isomorphic phenomenon is reported occasionally in LS after trauma like radiotherapy. A few case reports describe koebnerization of LS at injection sites. We describe the first such case in India of LS koebnerizing at insulin injection sites with dermoscopic features.

How to cite this article:
Vishwanath T, Ghate S, Shinde G, Lahoria V, Binny B, Sonwane A. Koebnerization of lichen sclerosus et atrophicus at insulin injection sites – A rare case with dermoscopic features.Indian J Dermatol 2021;66:224-224

How to cite this URL:
Vishwanath T, Ghate S, Shinde G, Lahoria V, Binny B, Sonwane A. Koebnerization of lichen sclerosus et atrophicus at insulin injection sites – A rare case with dermoscopic features. Indian J Dermatol [serial online] 2021 [cited 2021 Nov 29 ];66:224-224
Available from:

Full Text


Lichen sclerosus et atrophicus (LSEA) or lichen sclerosus (LS) is a benign chronic inflammatory dermatosis of unknown etiopathogenesis. It mostly affects prepubertal, perimenopausal, and postmenopausal women.

Extragenital LS occurs in 15–20% cases;[1] involves the neck, shoulder, and upper trunk in the form of porcelain white atrophic macules and plaques; and is generally asymptomatic.

LS exhibits occasional koebnerization[2] due to stimuli like radiotherapy[3] and physical trauma[4] and rarely occurs at injection sites.[5],[6]

Uptil date, there is only a single reported case of LS at sites of insulin injection.[7] We present one such case with dermoscopic and histologic features.

 Case History

A 65-year-old women, under treatment for diabetes mellitus with subcutaneous human insulin since the past 2 years, presented with gradual onset tightening of skin of abdominal injection sites with difficulty in injecting insulin since 4–5 months followed by gradual onset white discoloration of those sites since 3 months [Figure 1] and [Figure 2]. These were small to begin with otherwise asymptomatic. These lesions gradually extended to the present size. There were no other skin or genital complaints.{Figure 1}{Figure 2}

Examination revealed indurated well-defined depigmented patches on all four abdominal quadrants. A slightly atrophic surface was noted on closer examination. Dermoscopy (Dinolite video dermoscope, polarized mode) revealed follicular plugging in the form of yellowish plugs, telangiectasias, and whitish patches [Figure 3]. Based on the above findings, we kept our provisional diagnosis as LS.{Figure 3}

Histopathologic examination of a 4-mm punch biopsy revealed predominantly atrophic epidermis with hyalinization of upper dermis [Figure 4]. Lymphoplasmacytic infiltrate was noted around the dermal vessels [Figure 5] and [Figure 6]. A few dilated lymphatics were noted in the upper dermis [Figure 7]. A definitive diagnosis of LS was arrived via clinicopathologic correlation and dermoscopy.{Figure 4}{Figure 5}{Figure 6}{Figure 7}

The patient was asked to stop injecting insulin in the affected areas. We have prescribed 0.1% Mometasone Furoate cream to be applied twice daily and the patient will be followed up monthly.


LS is a chronic idiopathic inflammatory skin disease, which is underdiagnosed and undertreated. Prevalence of extragenital disease varies from 15% to 20%.[1] The exact pathogenesis is still a mystery. Immunological changes in T and B lymphocytes have been described. Vulvar LS has raised levels of Th1-specific cytokines, dense T-lymphocyte infiltration, and raised BIC/miR-155 expression and autoantibodies against extracellular matrix protein 1 (ECM-1) and BP180 antigen.[4] Another pathogenic mechanism which may be of relevance in the occasional koebnerization observed in LS[2] secondary to stimuli like radiotherapy[3] and scratching[4] may be altered ECM-1. Supposedly, in vulvar LS, trauma causes altered epitopes in ECM-1 leading to antigen recognition by T cells which leads to formation of antibodies and clinical manifestations of LS.[8] It is unknown if a similar mechanism is operative in koebnerized extragenital LS.

Extragenital LS manifests as atrophic ivory white-porcelain plaques and patches most commonly on the upper trunk, neck, and shoulder.[1]

A few cases of localized or generalized LS with or without morphea have been reported at injection sites.[5],[6]

To the best of our knowledge, only a single case of LS developing at sites of subcutaneous insulin injection has been reported.[7]

Dermoscopic features of LS described in the literature are sparse. Features noted in our patient include white-yellow patches and follicular plugging as described by Errichetti et al.[9]

Other authors have described dermoscopic features including white structureless areas and comedo-like openings.[10] An erythematous halo as marker of disease activity was also described.[11]

The major dermoscopic differential diagnosis of LS mentioned in the literature is morphea. A comparative analysis in this regard has been done by Errichetti et al.[9] Findings of yellow follicular plugs, bright white patches (both noted in the present case), and hemorrhagic spots point toward LS, whereas fibrotic beams and pigmentary structures were commoner in morphea.

Based on the above, we have clinically diagnosed our case as LS, which was corroborated on histopathology. To our knowledge, this represents the second case reported in the literature of LS koebnerizing at sites of subcutanous insulin injection and the first case with dermoscopic documentation of the disease in this rare presentation.

Treatment options for LS[1],[12] include corticosteroids (topical and intralesional), for example, clobetasol propionate ointment, topical calcineurin inhibitors, such as tacrolimus, phototherapy (psoralen + ultraviolet A or plain UV-A1), retinoids, estrogen, etc., but no definite cure apart from surgical excision is known (not feasible nor desirable in this case). As mentioned above, this patient has been advised to stop injecting insulin at these affected sites and 0.1% Mometasone Furoate cream has been prescribed twice daily.


Depigmented atrophic plaques at injection sites could point toward koebnerization of LS. Confirmation of the diagnosis is by biopsy or clinic–pathologic correlation and is supported by dermoscopy. Treatment mandates stopping injection at the affected sites and topical steroids as the mainstay of therapy.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


1Ganesan L, Parmar H, Das JK, Gangopadhyay A. Extragenital lichen sclerosus et atrophicus. Indian J Dermatol 2015;60:420.
2Thappa DM. The isomorphic phenomenon of Koebner. Indian J Dermatol Venereol Leprol 2004;70:187-9.
3Nemer KM, Anadkat MJ. Postirradiation Lichen Sclerosus et Atrophicus JAMA Dermatol 2017;153:1067-9.
4Kirtschig G. Lichen sclerosus—presentation, diagnosis and management. Deutsch Ärztebl Int 2016;113:337-43.
5Arif T, Adil M, Amin SS, Mahtab A. Concomitant morphea and lichen sclerosus et atrophicus in the same plaque at the site of intramuscular drug injection: An interesting case presentation. Acta Dermatovenerologica Alpina Pannonica et Adriatica 2018;27(2):111-13.
6Requena López S, Hidalgo García Y, Gómez Díez S, Vivanco Allende B. Morphea and extragenital lichen sclerosus et atrophicus after influenza vaccination. Actas Dermosifiliogr 2018;109:86-8.
7Monteagudo B, Cabanillas M, Bellido D, Suárez-Amor O, Ramírez-Santos A, de la Cruz A. Lichen sclerosus atrophicus at an insulin injection site: An unusual koebner phenomenon. Actas Dermosifiliogr 2010;101:563-65.
8Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: An update. Am J Clin Dermatol 2013;14:27-47.
9Errichetti E, Lallas A, Apalla Z, Di Stefani A, Stinco G. Dermoscopy of morphea and cutaneous lichen sclerosus: Clinicopathological correlation study and comparative analysis. Dermatology 2017;233:462-70.
10Shim WH, Jwa SW, Song M, Kim HS, Ko HC, Kim MB, et al. Diagnostic usefulness of dermatoscopy in differentiating lichen sclerous et atrophicus from morphea. J Am Acad Dermatol 2012;66:690-1.
11Garrido-Ríos AA, Alvarez-Garrido H, Sanz-Muñoz C, Aragoneses-Fraile H, Manchado-López P, Miranda-Romero A. Dermoscopy of extragenital lichen sclerosus. Arch Dermatol 2009;145:1468.
12Hasegawa M, Ishikawa O, Asano Y, Sato S, Jinnin M, Takehara K, et al. Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus. J Dermatol 2017;45:891-7.